Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea

BACKGROUND: The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries. South Korea expanded DAAs coverage through national health insurance. This study aims to analyse the cost-effectiveness of scale-up of hepatitis C screening and treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jungyeon, Haacker, Markus, Keshavjee, Salmaan, Atun, Rifat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570985/
https://www.ncbi.nlm.nih.gov/pubmed/31263587
http://dx.doi.org/10.1136/bmjgh-2019-001441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570985/
https://www.ncbi.nlm.nih.gov/pubmed/31263587
http://dx.doi.org/10.1136/bmjgh-2019-001441

Ejemplares similares